-
EP4051319
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4051319
| EP4051319 - ANTI-CD37 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE THEREOF [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 05.08.2022 Database last updated on 16.07.2024 | |
| Former | The international publication has been made Status updated on 10.05.2021 | Most recent event Tooltip | 21.12.2023 | Supplementary search report | published on 17.01.2024 [2024/03] | Applicant(s) | For all designated states R.P. Scherer Technologies, LLC 502 East John Street Carson City, NV 89706 / US | [2022/36] | Inventor(s) | 01 /
RABUKA, David 202 Stanford Avenue Kensington, California 94708 / US | 02 /
DRAKE, Penelope M. 3663 Swallow Court Castro Valley, California 94546 / US | 03 /
BARFIELD, Robyn M. 5959 Horton Street Suite 400 Emeryville, California 94608 / US | 04 /
KIM, Yun Cheol 587 Cabo Road Walnut Creek, California 94598 / US | [2022/36] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2022/36] | Application number, filing date | 20883180.0 | 30.10.2020 | [2022/36] | WO2020US58191 | Priority number, date | US201962928939P | 31.10.2019 Original published format: US 201962928939 P | [2022/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2021087248 | Date: | 06.05.2021 | Language: | EN | [2021/18] | Type: | A1 Application with search report | No.: | EP4051319 | Date: | 07.09.2022 | Language: | EN | The application published by WIPO in one of the EPO official languages on 06.05.2021 takes the place of the publication of the European patent application. | [2022/36] | Search report(s) | International search report - published on: | US | 06.05.2021 | (Supplementary) European search report - dispatched on: | EP | 20.12.2023 | Classification | IPC: | A61K47/68, C07D487/04, C07D498/18, C07D519/00, A61K47/50, A61K47/64, C07D405/12, A61P35/00, C07K16/28 | [2024/03] | CPC: |
C07D487/04 (EP,KR,US);
A61K47/6889 (EP,KR,US);
A61K31/5365 (KR);
A61K47/6803 (KR);
A61K47/68033 (EP,US);
A61K47/6849 (EP,KR,US);
A61P35/00 (EP);
A61P35/02 (KR);
C07D487/14 (KR);
|
| Former IPC [2022/36] | A61K47/50, A61K47/64, C07D405/12, C07D498/18 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/36] | Title | German: | ANTI-CD37-ANTIKÖRPER-MAYTANSIN-KONJUGATE UND VERFAHREN ZUR VERWENDUNG DAVON | [2022/36] | English: | ANTI-CD37 ANTIBODY-MAYTANSINE CONJUGATES AND METHODS OF USE THEREOF | [2022/36] | French: | CONJUGUÉS ANTICORPS ANTI-CD37-MAYTANSINE ET MÉTHODES D'UTILISATION DE CEUX-CI | [2022/36] | Entry into regional phase | 29.03.2022 | National basic fee paid | 29.03.2022 | Search fee paid | 29.03.2022 | Designation fee(s) paid | 29.03.2022 | Examination fee paid | Examination procedure | 29.03.2022 | Examination requested [2022/36] | 29.11.2022 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 15.09.2022 | Renewal fee patent year 03 | 27.10.2023 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [Y]WO2017083306 (SCHERER TECHNOLOGIES LLC R P [US]); | [Y]WO2018106895 (MOLECULAR TEMPLATES INC [US]) |